Carysil Reports Strong Q3 Performance with 46% EBITDA Growth and 68% Profit Jump

1 min read     Updated on 04 Feb 2026, 02:27 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Carysil delivered exceptional Q3 performance with EBITDA increasing 46% to ₹421 million and EBITDA margin expanding significantly to 18.95% from 14.18% year-on-year. The company also reported 68% growth in consolidated net profit to ₹210 million and 10% revenue growth to ₹2.2 billion, demonstrating strong operational efficiency and profitability enhancement.

31741056

*this image is generated using AI for illustrative purposes only.

Carysil has delivered impressive financial results for the third quarter, reporting significant growth across key performance metrics that underscores the company's strong operational performance and revenue expansion.

Financial Performance Overview

The company demonstrated robust growth across revenue, profitability, and operational efficiency metrics during the quarter, with substantial improvements in EBITDA performance and margin expansion.

Financial Metric Q3 Current Year Q3 Previous Year Growth
Revenue ₹2.2 billion ₹2 billion 10.00%
EBITDA ₹421 million ₹288 million 46.18%
EBITDA Margin 18.95% 14.18% +477 bps
Consolidated Net Profit ₹210 million ₹125 million 68.00%

Revenue and EBITDA Growth Analysis

Carysil's revenue increased to ₹2.2 billion in Q3 compared to ₹2 billion in the same quarter of the previous year, representing a solid 10% year-on-year growth. More significantly, the company's EBITDA surged to ₹421 million from ₹288 million, marking a substantial 46.18% year-on-year increase.

Operational Efficiency Enhancement

The company's EBITDA margin expanded significantly to 18.95% in Q3 from 14.18% in the corresponding quarter of the previous year, representing an improvement of 477 basis points. This margin expansion demonstrates Carysil's enhanced operational efficiency and improved cost management capabilities.

Profitability Performance

The 68% year-on-year increase in consolidated net profit reflects Carysil's exceptional ability to enhance profitability. The jump from ₹125 million to ₹210 million represents an additional ₹85 million in net profit generation compared to the same quarter in the previous fiscal year.

This substantial improvement in bottom-line performance, coupled with strong EBITDA growth and margin expansion, indicates positive momentum in the company's business operations and suggests effective management of costs and revenue optimization during the quarter.

Historical Stock Returns for CARYSIL

1 Day5 Days1 Month6 Months1 Year5 Years
+6.50%+35.45%+11.12%+21.82%+46.61%+433.39%

Carysil Limited Schedules Board Meeting for February 4, 2026 to Approve Q3FY26 Financial Results

1 min read     Updated on 20 Jan 2026, 12:20 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Carysil Limited has scheduled its Board of Directors meeting for February 4, 2026, to approve unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The company's trading window remains closed from January 1, 2026, and will reopen on February 7, 2026, following regulatory compliance requirements. The notification was issued on January 20, 2026, in accordance with SEBI listing regulations.

30437451

*this image is generated using AI for illustrative purposes only.

Carysil Limited has formally notified stock exchanges about its upcoming Board of Directors meeting scheduled for February 4, 2026, to review and approve the company's quarterly financial performance. The announcement, made on January 20, 2026, follows regulatory requirements under SEBI's listing obligations.

Board Meeting Details

The board meeting will focus on considering and approving the company's unaudited financial results for a specific reporting period. The meeting agenda encompasses both standalone and consolidated financial statements, providing comprehensive insights into the company's performance across all business segments.

Meeting Parameter: Details
Meeting Date: February 4, 2026
Meeting Day: Wednesday
Agenda: Q3FY26 Financial Results
Result Type: Unaudited Standalone and Consolidated
Reporting Period: Quarter and nine months ended December 31, 2025

Trading Window Restrictions

In accordance with the company's Code of Conduct for designated persons and regulatory compliance requirements, Carysil has implemented trading window restrictions. The trading window closure ensures compliance with insider trading regulations during the financial results preparation and announcement period.

Trading Window Status: Timeline
Closure Date: January 1, 2026
Reopening Date: February 7, 2026
Closure Duration: Until 48 hours after results declaration
Previous Intimation: December 26, 2025

Regulatory Compliance

The notification was issued pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to provide prior intimation to stock exchanges regarding board meetings that will consider financial results.

The company has communicated this information to both major Indian stock exchanges where its shares are listed. The formal notification ensures transparency and provides adequate notice to investors and market participants about the upcoming financial disclosure.

Corporate Communication

The official communication was signed by Reena Shah, Company Secretary and Compliance Officer, on January 20, 2026. The notification was simultaneously sent to BSE Limited and National Stock Exchange of India Limited, maintaining compliance with dual listing requirements and ensuring comprehensive market communication.

Historical Stock Returns for CARYSIL

1 Day5 Days1 Month6 Months1 Year5 Years
+6.50%+35.45%+11.12%+21.82%+46.61%+433.39%

More News on CARYSIL

1 Year Returns:+46.61%